RCMNY
NBRV

Rubric Capital Management (New York)’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Rubric Capital Management (New York)’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,200
Closed -$1.79M – 63
2017
Q4 		$1.79M Hold
1,200
– – 0.22% 49
2017
Q3 		$2.46M Buy
+1,200
New +$2.81M 0.22% 49

Other funds holding NBRV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Rubric Capital Management (New York)'s NBRV Position: Q1 2018 in Review

Rubric Capital Management (New York) sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2018, closing a stake of 1,200 shares — an estimated $1.79M sold.

Rubric Capital Management (New York) first reported a position in NBRV in Q3 2017 and held it in 2 quarters. The position peaked at $2.46M in Q3 2017. 46 funds tracked by Wall St. Rank hold NBRV as of Q1 2018.

  • Rubric Capital Management (New York) reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2018 after selling out during the quarter.
  • Rubric Capital Management (New York) sold 1,200 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2018, an estimated $1.79M.
  • Rubric Capital Management (New York) first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2017 and held it in 2 quarters.
  • Rubric Capital Management (New York)'s Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $2.46M in Q3 2017.
  • 46 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2018.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2018, filed 14 May 2018.